Shyam Prabhakaran
Concepts (469)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 97 | 2020 | 685 | 27.030 |
Why?
| Brain Ischemia | 45 | 2020 | 303 | 14.440 |
Why?
| Cerebral Hemorrhage | 41 | 2020 | 265 | 9.240 |
Why?
| Thrombolytic Therapy | 26 | 2020 | 172 | 8.480 |
Why?
| Ischemic Attack, Transient | 19 | 2020 | 166 | 8.300 |
Why?
| Fibrinolytic Agents | 23 | 2019 | 162 | 7.700 |
Why?
| Tissue Plasminogen Activator | 21 | 2018 | 130 | 6.710 |
Why?
| Intracranial Arteriosclerosis | 15 | 2020 | 34 | 5.150 |
Why?
| Subarachnoid Hemorrhage | 18 | 2020 | 139 | 4.650 |
Why?
| Cerebral Infarction | 10 | 2019 | 59 | 3.990 |
Why?
| Anticoagulants | 11 | 2018 | 340 | 3.740 |
Why?
| Aged | 116 | 2020 | 16862 | 3.450 |
Why?
| Quality of Life | 9 | 2020 | 1140 | 3.230 |
Why?
| Middle Aged | 118 | 2020 | 23594 | 3.020 |
Why?
| Severity of Illness Index | 22 | 2020 | 1620 | 2.970 |
Why?
| Male | 135 | 2020 | 38562 | 2.860 |
Why?
| Female | 136 | 2020 | 40857 | 2.740 |
Why?
| Disability Evaluation | 9 | 2020 | 118 | 2.740 |
Why?
| Humans | 183 | 2020 | 74352 | 2.680 |
Why?
| Cerebrovascular Circulation | 12 | 2020 | 190 | 2.610 |
Why?
| Atrial Fibrillation | 7 | 2018 | 218 | 2.600 |
Why?
| Thrombectomy | 5 | 2019 | 53 | 2.590 |
Why?
| Hospital Mortality | 9 | 2015 | 280 | 2.470 |
Why?
| Aged, 80 and over | 53 | 2020 | 6047 | 2.420 |
Why?
| Hospitalization | 10 | 2019 | 646 | 2.330 |
Why?
| Risk Factors | 47 | 2020 | 4855 | 2.260 |
Why?
| Brain Infarction | 7 | 2020 | 22 | 2.220 |
Why?
| Registries | 20 | 2020 | 542 | 2.130 |
Why?
| Warfarin | 5 | 2014 | 100 | 2.110 |
Why?
| Prospective Studies | 41 | 2020 | 3527 | 2.050 |
Why?
| Infarction, Middle Cerebral Artery | 6 | 2014 | 27 | 1.970 |
Why?
| Platelet Aggregation Inhibitors | 7 | 2019 | 93 | 1.970 |
Why?
| Cerebral Angiography | 8 | 2014 | 200 | 1.940 |
Why?
| Magnetic Resonance Imaging | 22 | 2019 | 2911 | 1.860 |
Why?
| Diffusion Magnetic Resonance Imaging | 11 | 2019 | 209 | 1.860 |
Why?
| Cohort Studies | 29 | 2018 | 2395 | 1.780 |
Why?
| Treatment Outcome | 39 | 2020 | 7077 | 1.720 |
Why?
| Emergency Service, Hospital | 6 | 2019 | 349 | 1.710 |
Why?
| Endovascular Procedures | 6 | 2016 | 107 | 1.660 |
Why?
| Retrospective Studies | 37 | 2020 | 6340 | 1.620 |
Why?
| Cerebral Arteries | 4 | 2017 | 81 | 1.580 |
Why?
| Emergency Medical Services | 5 | 2018 | 138 | 1.550 |
Why?
| Venous Thrombosis | 3 | 2015 | 195 | 1.540 |
Why?
| Stents | 8 | 2019 | 344 | 1.460 |
Why?
| Neuroimaging | 7 | 2019 | 74 | 1.450 |
Why?
| Time Factors | 29 | 2020 | 5209 | 1.430 |
Why?
| Predictive Value of Tests | 22 | 2020 | 1561 | 1.380 |
Why?
| Magnetic Resonance Angiography | 10 | 2020 | 215 | 1.370 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 431 | 1.310 |
Why?
| Telemetry | 3 | 2017 | 35 | 1.300 |
Why?
| Reperfusion | 5 | 2016 | 26 | 1.300 |
Why?
| Perfusion Imaging | 6 | 2020 | 40 | 1.290 |
Why?
| Hospitals | 4 | 2017 | 150 | 1.270 |
Why?
| Seizures | 8 | 2020 | 234 | 1.230 |
Why?
| Nervous System Diseases | 3 | 2020 | 142 | 1.200 |
Why?
| Recovery of Function | 6 | 2020 | 245 | 1.180 |
Why?
| Brain | 11 | 2019 | 1952 | 1.180 |
Why?
| Diagnostic Errors | 3 | 2017 | 175 | 1.170 |
Why?
| Public Health | 2 | 2018 | 95 | 1.170 |
Why?
| Referral and Consultation | 2 | 2019 | 281 | 1.140 |
Why?
| Adult | 46 | 2020 | 23811 | 1.100 |
Why?
| Intracranial Hemorrhages | 4 | 2020 | 71 | 1.100 |
Why?
| beta-Alanine | 2 | 2012 | 6 | 1.090 |
Why?
| Triage | 5 | 2015 | 67 | 1.090 |
Why?
| Tomography, X-Ray Computed | 19 | 2020 | 2424 | 1.060 |
Why?
| Vasospasm, Intracranial | 2 | 2012 | 35 | 1.040 |
Why?
| Heart Diseases | 3 | 2020 | 299 | 1.010 |
Why?
| Neuropsychological Tests | 2 | 2020 | 430 | 1.010 |
Why?
| Carotid Artery, Internal, Dissection | 2 | 2014 | 11 | 1.000 |
Why?
| Benzimidazoles | 2 | 2012 | 128 | 0.970 |
Why?
| Activities of Daily Living | 2 | 2019 | 173 | 0.960 |
Why?
| Models, Economic | 2 | 2019 | 52 | 0.950 |
Why?
| Patient Readmission | 4 | 2020 | 246 | 0.940 |
Why?
| Disabled Persons | 2 | 2019 | 46 | 0.920 |
Why?
| Acute Disease | 10 | 2019 | 823 | 0.920 |
Why?
| Actigraphy | 1 | 2020 | 50 | 0.900 |
Why?
| Quality Indicators, Health Care | 3 | 2019 | 121 | 0.890 |
Why?
| International Normalized Ratio | 3 | 2014 | 35 | 0.890 |
Why?
| Prognosis | 21 | 2020 | 3377 | 0.880 |
Why?
| Patient Admission | 3 | 2019 | 94 | 0.880 |
Why?
| Chicago | 9 | 2020 | 1275 | 0.870 |
Why?
| Quality Improvement | 3 | 2019 | 295 | 0.860 |
Why?
| Natural Language Processing | 1 | 2019 | 20 | 0.860 |
Why?
| Data Mining | 1 | 2019 | 39 | 0.840 |
Why?
| Hypothermia, Induced | 2 | 2010 | 69 | 0.840 |
Why?
| Intracranial Thrombosis | 2 | 2008 | 19 | 0.810 |
Why?
| Post-Exposure Prophylaxis | 1 | 2018 | 2 | 0.800 |
Why?
| Cognition Disorders | 1 | 2020 | 235 | 0.800 |
Why?
| Dementia | 1 | 2019 | 148 | 0.790 |
Why?
| Ischemia | 4 | 2019 | 231 | 0.780 |
Why?
| Electronic Health Records | 3 | 2019 | 214 | 0.770 |
Why?
| Graft Occlusion, Vascular | 2 | 2009 | 98 | 0.770 |
Why?
| Logistic Models | 12 | 2018 | 1085 | 0.770 |
Why?
| Emergency Medical Service Communication Systems | 1 | 2017 | 4 | 0.770 |
Why?
| Disease Management | 3 | 2017 | 292 | 0.770 |
Why?
| Hospitals, Urban | 1 | 2017 | 45 | 0.760 |
Why?
| Cerebrovascular Disorders | 2 | 2009 | 144 | 0.750 |
Why?
| Cerebral Revascularization | 2 | 2014 | 26 | 0.750 |
Why?
| Arterial Occlusive Diseases | 1 | 2018 | 98 | 0.750 |
Why?
| Autonomic Nervous System Diseases | 1 | 2017 | 19 | 0.750 |
Why?
| Brain Edema | 2 | 2018 | 46 | 0.740 |
Why?
| Carotid Artery, Internal | 4 | 2020 | 70 | 0.740 |
Why?
| Echocardiography | 3 | 2020 | 759 | 0.740 |
Why?
| Longitudinal Studies | 5 | 2020 | 858 | 0.730 |
Why?
| Hemodynamics | 4 | 2020 | 649 | 0.730 |
Why?
| Life Style | 3 | 2020 | 173 | 0.720 |
Why?
| Recurrence | 11 | 2020 | 1106 | 0.720 |
Why?
| Personnel, Hospital | 1 | 2016 | 28 | 0.720 |
Why?
| Practice Guidelines as Topic | 5 | 2018 | 1018 | 0.720 |
Why?
| Inservice Training | 1 | 2016 | 35 | 0.710 |
Why?
| Carotid Stenosis | 3 | 2018 | 96 | 0.710 |
Why?
| Early Medical Intervention | 1 | 2016 | 13 | 0.700 |
Why?
| Venous Thromboembolism | 1 | 2018 | 95 | 0.690 |
Why?
| Substance Abuse Detection | 1 | 2015 | 16 | 0.680 |
Why?
| Toxicology | 1 | 2015 | 15 | 0.680 |
Why?
| Hospitals, Community | 1 | 2015 | 25 | 0.680 |
Why?
| Posterior Leukoencephalopathy Syndrome | 2 | 2013 | 8 | 0.670 |
Why?
| Health Promotion | 1 | 2018 | 155 | 0.670 |
Why?
| Brain Mapping | 1 | 2019 | 505 | 0.670 |
Why?
| Academic Medical Centers | 2 | 2015 | 347 | 0.660 |
Why?
| Informed Consent | 1 | 2018 | 226 | 0.660 |
Why?
| Middle Cerebral Artery | 6 | 2020 | 17 | 0.660 |
Why?
| Patient Care Team | 2 | 2019 | 243 | 0.640 |
Why?
| Odds Ratio | 5 | 2020 | 666 | 0.640 |
Why?
| Vertebral Artery Dissection | 1 | 2014 | 9 | 0.640 |
Why?
| Intracranial Aneurysm | 3 | 2020 | 161 | 0.620 |
Why?
| Remote Consultation | 1 | 2014 | 12 | 0.620 |
Why?
| Foramen Ovale, Patent | 1 | 2014 | 14 | 0.610 |
Why?
| Echocardiography, Transesophageal | 1 | 2017 | 322 | 0.610 |
Why?
| Pelvis | 1 | 2014 | 74 | 0.600 |
Why?
| Thrombophilia | 1 | 2013 | 17 | 0.590 |
Why?
| Tachycardia | 1 | 2013 | 47 | 0.590 |
Why?
| Heart | 1 | 2017 | 489 | 0.590 |
Why?
| Magnesium | 3 | 2020 | 187 | 0.580 |
Why?
| Heart Septal Defects, Atrial | 1 | 2013 | 61 | 0.580 |
Why?
| Communication | 1 | 2017 | 367 | 0.580 |
Why?
| Hematoma, Subdural | 1 | 2013 | 19 | 0.580 |
Why?
| Prevalence | 7 | 2017 | 1110 | 0.580 |
Why?
| Thiazoles | 1 | 2014 | 125 | 0.570 |
Why?
| Anticonvulsants | 3 | 2020 | 110 | 0.560 |
Why?
| Encephalocele | 1 | 2013 | 23 | 0.560 |
Why?
| Sleep | 1 | 2017 | 379 | 0.550 |
Why?
| ROC Curve | 5 | 2020 | 763 | 0.540 |
Why?
| Injections, Intra-Arterial | 2 | 2013 | 39 | 0.540 |
Why?
| Intracranial Hypertension | 1 | 2013 | 43 | 0.540 |
Why?
| Basilar Artery | 2 | 2011 | 35 | 0.530 |
Why?
| Nicardipine | 1 | 2011 | 7 | 0.520 |
Why?
| Health Facilities | 1 | 2011 | 21 | 0.520 |
Why?
| Pyridines | 1 | 2014 | 285 | 0.520 |
Why?
| Putaminal Hemorrhage | 1 | 2011 | 1 | 0.510 |
Why?
| Carotid Artery Diseases | 2 | 2016 | 111 | 0.510 |
Why?
| Putamen | 1 | 2011 | 16 | 0.510 |
Why?
| Secondary Prevention | 5 | 2014 | 155 | 0.500 |
Why?
| Angioplasty | 2 | 2010 | 66 | 0.500 |
Why?
| Decision Support Techniques | 3 | 2020 | 142 | 0.500 |
Why?
| Antihypertensive Agents | 2 | 2019 | 532 | 0.500 |
Why?
| Hypotension | 1 | 2011 | 64 | 0.500 |
Why?
| Risk Assessment | 11 | 2020 | 2053 | 0.500 |
Why?
| Clinical Protocols | 2 | 2009 | 150 | 0.490 |
Why?
| Paresis | 2 | 2008 | 12 | 0.490 |
Why?
| Transportation of Patients | 1 | 2011 | 25 | 0.490 |
Why?
| Community Health Centers | 1 | 2012 | 92 | 0.490 |
Why?
| Follow-Up Studies | 9 | 2017 | 3605 | 0.480 |
Why?
| Multivariate Analysis | 7 | 2018 | 991 | 0.480 |
Why?
| United States | 11 | 2020 | 5499 | 0.470 |
Why?
| Intracranial Embolism | 2 | 2020 | 15 | 0.470 |
Why?
| Electrocardiography, Ambulatory | 1 | 2010 | 25 | 0.470 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2014 | 770 | 0.470 |
Why?
| Assisted Circulation | 1 | 2010 | 13 | 0.470 |
Why?
| Vasodilator Agents | 1 | 2011 | 170 | 0.470 |
Why?
| Health Education | 1 | 2011 | 97 | 0.450 |
Why?
| Aspirin | 2 | 2007 | 120 | 0.450 |
Why?
| Ultrasonography, Doppler, Transcranial | 3 | 2020 | 16 | 0.440 |
Why?
| Sex Characteristics | 2 | 2008 | 287 | 0.430 |
Why?
| Patient Discharge | 4 | 2020 | 175 | 0.430 |
Why?
| Constriction, Pathologic | 5 | 2019 | 191 | 0.420 |
Why?
| Hepatic Encephalopathy | 2 | 2019 | 29 | 0.420 |
Why?
| Upper Extremity | 2 | 2020 | 46 | 0.420 |
Why?
| Gastrostomy | 2 | 2019 | 75 | 0.410 |
Why?
| Reproducibility of Results | 6 | 2019 | 2485 | 0.410 |
Why?
| Kidney Diseases | 1 | 2012 | 415 | 0.400 |
Why?
| Glasgow Coma Scale | 4 | 2018 | 43 | 0.390 |
Why?
| Continental Population Groups | 4 | 2019 | 273 | 0.390 |
Why?
| Ticlopidine | 1 | 2007 | 21 | 0.390 |
Why?
| Illinois | 4 | 2019 | 415 | 0.390 |
Why?
| Socioeconomic Factors | 2 | 2020 | 516 | 0.380 |
Why?
| Cross-Sectional Studies | 3 | 2020 | 1171 | 0.380 |
Why?
| Movement Disorders | 1 | 2007 | 43 | 0.380 |
Why?
| European Continental Ancestry Group | 4 | 2019 | 1022 | 0.380 |
Why?
| Hemostatics | 2 | 2019 | 43 | 0.370 |
Why?
| Carotid Arteries | 2 | 2009 | 126 | 0.370 |
Why?
| Young Adult | 9 | 2020 | 5159 | 0.370 |
Why?
| Blood Pressure | 5 | 2019 | 1127 | 0.360 |
Why?
| Health Knowledge, Attitudes, Practice | 5 | 2020 | 468 | 0.350 |
Why?
| Hypertensive Encephalopathy | 1 | 2006 | 1 | 0.350 |
Why?
| Fever | 2 | 2019 | 101 | 0.350 |
Why?
| Outpatients | 2 | 2017 | 68 | 0.350 |
Why?
| Gadolinium | 1 | 2006 | 95 | 0.340 |
Why?
| Age Factors | 6 | 2018 | 1811 | 0.340 |
Why?
| Aneurysm, Dissecting | 1 | 2006 | 61 | 0.340 |
Why?
| Blood Platelets | 2 | 2018 | 137 | 0.340 |
Why?
| Blood Vessel Prosthesis | 1 | 2007 | 204 | 0.330 |
Why?
| Medulla Oblongata | 1 | 2006 | 75 | 0.330 |
Why?
| Circle of Willis | 2 | 2017 | 6 | 0.320 |
Why?
| Area Under Curve | 2 | 2018 | 333 | 0.320 |
Why?
| Early Diagnosis | 3 | 2019 | 112 | 0.320 |
Why?
| Consensus | 2 | 2018 | 229 | 0.310 |
Why?
| Neurologic Examination | 3 | 2015 | 117 | 0.300 |
Why?
| Imaging, Three-Dimensional | 2 | 2019 | 546 | 0.290 |
Why?
| Diagnosis, Differential | 2 | 2018 | 1554 | 0.280 |
Why?
| Comorbidity | 3 | 2015 | 833 | 0.280 |
Why?
| Patient Selection | 4 | 2020 | 638 | 0.280 |
Why?
| Sensitivity and Specificity | 3 | 2018 | 2039 | 0.270 |
Why?
| Atherosclerosis | 2 | 2019 | 209 | 0.260 |
Why?
| Ethnic Groups | 3 | 2018 | 422 | 0.250 |
Why?
| Plaque, Atherosclerotic | 2 | 2020 | 35 | 0.240 |
Why?
| Hemostasis | 2 | 2018 | 19 | 0.240 |
Why?
| African Continental Ancestry Group | 2 | 2018 | 539 | 0.240 |
Why?
| Platelet Function Tests | 2 | 2018 | 8 | 0.240 |
Why?
| Cerebrospinal Fluid Proteins | 1 | 2020 | 9 | 0.230 |
Why?
| Alcohol Drinking | 2 | 2020 | 253 | 0.230 |
Why?
| Hypesthesia | 2 | 2011 | 12 | 0.230 |
Why?
| Physical Therapy Specialty | 1 | 2019 | 2 | 0.230 |
Why?
| Speech Therapy | 1 | 2019 | 7 | 0.230 |
Why?
| Atrial Function, Left | 1 | 2020 | 37 | 0.230 |
Why?
| Financing, Organized | 1 | 2019 | 11 | 0.230 |
Why?
| Therapeutic Equipoise | 1 | 2019 | 4 | 0.230 |
Why?
| Anisotropy | 1 | 2019 | 53 | 0.220 |
Why?
| Occupational Therapy | 1 | 2019 | 17 | 0.220 |
Why?
| Cerebral Ventricles | 2 | 2013 | 86 | 0.220 |
Why?
| Leukoencephalopathies | 1 | 2019 | 11 | 0.220 |
Why?
| Diffusion | 1 | 2019 | 103 | 0.220 |
Why?
| Basal Ganglia Cerebrovascular Disease | 1 | 2019 | 3 | 0.220 |
Why?
| Hypertension | 5 | 2017 | 1141 | 0.220 |
Why?
| Sex Factors | 3 | 2020 | 1035 | 0.220 |
Why?
| Vision Disorders | 2 | 2011 | 67 | 0.220 |
Why?
| Aorta, Thoracic | 2 | 2017 | 147 | 0.220 |
Why?
| National Institutes of Health (U.S.) | 1 | 2019 | 93 | 0.220 |
Why?
| Parasympathetic Nervous System | 1 | 2019 | 33 | 0.220 |
Why?
| Blood Flow Velocity | 3 | 2019 | 185 | 0.210 |
Why?
| Middle East | 1 | 2018 | 15 | 0.210 |
Why?
| Hospitals, Public | 1 | 2018 | 16 | 0.210 |
Why?
| Mentors | 1 | 2019 | 56 | 0.210 |
Why?
| Fellowships and Scholarships | 1 | 2019 | 83 | 0.210 |
Why?
| Clinical Trials as Topic | 3 | 2009 | 1124 | 0.210 |
Why?
| Blood Pressure Determination | 1 | 2019 | 90 | 0.210 |
Why?
| Automation | 1 | 2019 | 115 | 0.210 |
Why?
| Neuroprotective Agents | 2 | 2017 | 91 | 0.210 |
Why?
| Hispanic Americans | 2 | 2019 | 354 | 0.210 |
Why?
| Postural Balance | 1 | 2018 | 28 | 0.200 |
Why?
| Heart Atria | 1 | 2020 | 209 | 0.200 |
Why?
| Health Status Disparities | 1 | 2020 | 128 | 0.200 |
Why?
| Costs and Cost Analysis | 1 | 2019 | 138 | 0.200 |
Why?
| Frontal Lobe | 1 | 2019 | 133 | 0.200 |
Why?
| Platelet Activation | 1 | 2018 | 13 | 0.200 |
Why?
| Preventive Health Services | 1 | 2018 | 47 | 0.200 |
Why?
| Delirium | 1 | 2018 | 61 | 0.200 |
Why?
| Dose-Response Relationship, Drug | 2 | 2014 | 2040 | 0.200 |
Why?
| Diagnostic Imaging | 2 | 2015 | 419 | 0.200 |
Why?
| Cultural Characteristics | 1 | 2018 | 30 | 0.200 |
Why?
| Critical Care | 2 | 2013 | 320 | 0.190 |
Why?
| Ambulances | 1 | 2017 | 12 | 0.190 |
Why?
| Liver Cirrhosis | 1 | 2019 | 228 | 0.190 |
Why?
| Disease Progression | 6 | 2019 | 1341 | 0.190 |
Why?
| Decision Support Systems, Clinical | 1 | 2018 | 102 | 0.190 |
Why?
| Brain Diseases | 1 | 2018 | 180 | 0.190 |
Why?
| Focus Groups | 1 | 2018 | 134 | 0.190 |
Why?
| Hematoma | 1 | 2018 | 76 | 0.190 |
Why?
| Moyamoya Disease | 1 | 2017 | 7 | 0.190 |
Why?
| Urban Health Services | 1 | 2017 | 43 | 0.190 |
Why?
| Pattern Recognition, Automated | 1 | 2019 | 232 | 0.190 |
Why?
| New York City | 2 | 2007 | 55 | 0.190 |
Why?
| Drug Resistance | 2 | 2008 | 255 | 0.190 |
Why?
| Age Distribution | 2 | 2007 | 200 | 0.180 |
Why?
| Administration, Oral | 2 | 2018 | 673 | 0.180 |
Why?
| Missouri | 1 | 2016 | 29 | 0.180 |
Why?
| Education, Nursing, Continuing | 1 | 2016 | 8 | 0.180 |
Why?
| Research Design | 1 | 2020 | 531 | 0.180 |
Why?
| Qualitative Research | 1 | 2018 | 200 | 0.180 |
Why?
| Aortic Diseases | 1 | 2017 | 104 | 0.180 |
Why?
| Heart Rate | 1 | 2019 | 483 | 0.180 |
Why?
| Leptospirosis | 1 | 2016 | 5 | 0.180 |
Why?
| Drug Utilization | 2 | 2020 | 66 | 0.180 |
Why?
| Incidence | 5 | 2018 | 1485 | 0.180 |
Why?
| Nursing Staff, Hospital | 1 | 2016 | 36 | 0.180 |
Why?
| Electrocardiography | 3 | 2020 | 510 | 0.170 |
Why?
| Image Interpretation, Computer-Assisted | 2 | 2019 | 669 | 0.170 |
Why?
| Algorithms | 3 | 2017 | 1771 | 0.170 |
Why?
| Aorta | 1 | 2017 | 263 | 0.170 |
Why?
| Hemorrhage | 2 | 2015 | 215 | 0.170 |
Why?
| Mobility Limitation | 1 | 2015 | 13 | 0.170 |
Why?
| Adolescent | 4 | 2020 | 8375 | 0.170 |
Why?
| Education, Medical, Continuing | 1 | 2016 | 91 | 0.170 |
Why?
| Medical Staff, Hospital | 1 | 2016 | 108 | 0.160 |
Why?
| Asian Continental Ancestry Group | 1 | 2017 | 323 | 0.160 |
Why?
| Inpatients | 1 | 2018 | 206 | 0.160 |
Why?
| Healthcare Disparities | 1 | 2019 | 277 | 0.160 |
Why?
| Monitoring, Ambulatory | 1 | 2015 | 31 | 0.160 |
Why?
| Cooperative Behavior | 1 | 2016 | 165 | 0.160 |
Why?
| Biomedical Research | 1 | 2019 | 317 | 0.160 |
Why?
| Intensive Care Units | 5 | 2019 | 318 | 0.160 |
Why?
| Positron-Emission Tomography | 1 | 2017 | 246 | 0.160 |
Why?
| Interdisciplinary Communication | 1 | 2016 | 130 | 0.160 |
Why?
| Databases, Factual | 2 | 2018 | 740 | 0.160 |
Why?
| Program Evaluation | 1 | 2016 | 283 | 0.160 |
Why?
| Deamino Arginine Vasopressin | 1 | 2014 | 6 | 0.160 |
Why?
| Pneumonia, Viral | 1 | 2020 | 294 | 0.160 |
Why?
| Coronavirus Infections | 1 | 2020 | 277 | 0.160 |
Why?
| Blood Coagulation Factors | 1 | 2014 | 19 | 0.160 |
Why?
| Fibrinogen | 1 | 2014 | 51 | 0.160 |
Why?
| Proportional Hazards Models | 2 | 2015 | 809 | 0.150 |
Why?
| Cardiac Surgical Procedures | 1 | 2018 | 399 | 0.150 |
Why?
| Infusions, Intravenous | 1 | 2015 | 434 | 0.150 |
Why?
| Functional Neuroimaging | 1 | 2013 | 23 | 0.150 |
Why?
| Image Processing, Computer-Assisted | 3 | 2018 | 1151 | 0.150 |
Why?
| African Americans | 2 | 2019 | 998 | 0.140 |
Why?
| Lipids | 1 | 2016 | 376 | 0.140 |
Why?
| Risk | 4 | 2018 | 671 | 0.140 |
Why?
| Data Interpretation, Statistical | 2 | 2012 | 296 | 0.140 |
Why?
| Learning | 1 | 2016 | 229 | 0.140 |
Why?
| Arteries | 1 | 2014 | 180 | 0.140 |
Why?
| Leukoaraiosis | 1 | 2013 | 1 | 0.140 |
Why?
| Risk Reduction Behavior | 1 | 2014 | 98 | 0.140 |
Why?
| Headache | 2 | 2011 | 66 | 0.140 |
Why?
| Troponin I | 1 | 2013 | 27 | 0.140 |
Why?
| Blood Coagulation Disorders | 1 | 2013 | 36 | 0.140 |
Why?
| Factor VIIa | 1 | 2012 | 4 | 0.140 |
Why?
| Urban Population | 1 | 2014 | 210 | 0.140 |
Why?
| Partial Thromboplastin Time | 1 | 2012 | 16 | 0.140 |
Why?
| Plasma | 1 | 2012 | 43 | 0.140 |
Why?
| Platelet Count | 1 | 2012 | 78 | 0.130 |
Why?
| Kidney Function Tests | 1 | 2012 | 127 | 0.130 |
Why?
| Diffusion Tensor Imaging | 1 | 2012 | 48 | 0.130 |
Why?
| Health Facility Size | 1 | 2011 | 10 | 0.130 |
Why?
| Infusions, Intra-Arterial | 1 | 2011 | 33 | 0.130 |
Why?
| Blood Coagulation | 1 | 2012 | 77 | 0.130 |
Why?
| Angioplasty, Balloon | 2 | 2009 | 92 | 0.130 |
Why?
| Decision Trees | 1 | 2011 | 63 | 0.130 |
Why?
| Coronary Disease | 1 | 2013 | 308 | 0.130 |
Why?
| Intracranial Pressure | 1 | 2011 | 62 | 0.130 |
Why?
| Endocarditis | 1 | 2011 | 10 | 0.130 |
Why?
| Certification | 1 | 2011 | 50 | 0.130 |
Why?
| Injections, Intravenous | 1 | 2011 | 260 | 0.130 |
Why?
| Double-Blind Method | 2 | 2014 | 1760 | 0.120 |
Why?
| Vertebral Artery | 1 | 2011 | 21 | 0.120 |
Why?
| Confidence Intervals | 1 | 2011 | 234 | 0.120 |
Why?
| International Classification of Diseases | 1 | 2011 | 65 | 0.120 |
Why?
| Speech Disorders | 1 | 2011 | 18 | 0.120 |
Why?
| Quality-Adjusted Life Years | 1 | 2011 | 98 | 0.120 |
Why?
| Audiovisual Aids | 1 | 2011 | 4 | 0.120 |
Why?
| Inflammation | 2 | 2007 | 730 | 0.120 |
Why?
| Outpatient Clinics, Hospital | 1 | 2011 | 25 | 0.120 |
Why?
| Gait Disorders, Neurologic | 1 | 2011 | 20 | 0.120 |
Why?
| Glomerular Filtration Rate | 1 | 2012 | 343 | 0.120 |
Why?
| Mass Screening | 1 | 2015 | 567 | 0.120 |
Why?
| Cerebral Amyloid Angiopathy | 1 | 2010 | 7 | 0.120 |
Why?
| Heart Valve Diseases | 1 | 2011 | 95 | 0.120 |
Why?
| Observer Variation | 2 | 2015 | 636 | 0.120 |
Why?
| Liver Transplantation | 1 | 2018 | 1149 | 0.110 |
Why?
| Case-Control Studies | 2 | 2016 | 1694 | 0.110 |
Why?
| Iatrogenic Disease | 1 | 2010 | 59 | 0.110 |
Why?
| Postoperative Complications | 2 | 2018 | 2107 | 0.110 |
Why?
| Analysis of Variance | 1 | 2012 | 949 | 0.110 |
Why?
| Health Services Accessibility | 1 | 2013 | 345 | 0.110 |
Why?
| Cost-Benefit Analysis | 1 | 2011 | 364 | 0.110 |
Why?
| Drug Therapy, Combination | 2 | 2010 | 943 | 0.110 |
Why?
| Survival Rate | 1 | 2014 | 1817 | 0.110 |
Why?
| Circadian Rhythm | 1 | 2012 | 288 | 0.110 |
Why?
| Drug Synergism | 1 | 2010 | 322 | 0.110 |
Why?
| Vertebrobasilar Insufficiency | 1 | 2009 | 15 | 0.110 |
Why?
| Language Disorders | 1 | 2008 | 10 | 0.110 |
Why?
| Vertigo | 1 | 2008 | 11 | 0.110 |
Why?
| Radiography | 1 | 2011 | 848 | 0.100 |
Why?
| Migraine Disorders | 1 | 2008 | 28 | 0.100 |
Why?
| Health Care Surveys | 2 | 2020 | 285 | 0.100 |
Why?
| Blood-Brain Barrier | 1 | 2008 | 60 | 0.100 |
Why?
| Length of Stay | 3 | 2019 | 623 | 0.100 |
Why?
| Emergencies | 1 | 2009 | 106 | 0.100 |
Why?
| North America | 2 | 2018 | 168 | 0.100 |
Why?
| Drug Administration Schedule | 2 | 2020 | 946 | 0.090 |
Why?
| New York | 1 | 2007 | 58 | 0.090 |
Why?
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2007 | 9 | 0.090 |
Why?
| Brain Stem Infarctions | 1 | 2007 | 3 | 0.090 |
Why?
| Bacteroides Infections | 1 | 2007 | 5 | 0.090 |
Why?
| Sex Distribution | 1 | 2007 | 165 | 0.090 |
Why?
| Meningitis, Bacterial | 1 | 2007 | 12 | 0.090 |
Why?
| Cerebellar Diseases | 1 | 2007 | 17 | 0.090 |
Why?
| Artifacts | 1 | 2009 | 223 | 0.090 |
Why?
| Abdominal Abscess | 1 | 2007 | 18 | 0.090 |
Why?
| Ultrasonic Therapy | 1 | 2007 | 25 | 0.090 |
Why?
| Causality | 1 | 2007 | 68 | 0.090 |
Why?
| Age of Onset | 1 | 2007 | 295 | 0.090 |
Why?
| Students, Medical | 1 | 2011 | 286 | 0.090 |
Why?
| Vascular Diseases | 1 | 2007 | 114 | 0.090 |
Why?
| Models, Statistical | 2 | 2007 | 558 | 0.090 |
Why?
| Brain Stem | 1 | 2006 | 153 | 0.080 |
Why?
| Collagen | 1 | 2006 | 272 | 0.080 |
Why?
| Clostridium Infections | 1 | 2007 | 132 | 0.080 |
Why?
| Ultrasonography | 1 | 2007 | 655 | 0.080 |
Why?
| Catheterization | 1 | 2005 | 243 | 0.080 |
Why?
| Myocardial Infarction | 1 | 2007 | 341 | 0.070 |
Why?
| Attitude of Health Personnel | 2 | 2020 | 618 | 0.070 |
Why?
| Ventriculostomy | 2 | 2013 | 25 | 0.070 |
Why?
| Aortic Valve | 2 | 2017 | 162 | 0.070 |
Why?
| Animals | 4 | 2016 | 25427 | 0.070 |
Why?
| Cognition | 2 | 2018 | 447 | 0.070 |
Why?
| Regression Analysis | 2 | 2015 | 615 | 0.070 |
Why?
| Rupture, Spontaneous | 1 | 2020 | 47 | 0.060 |
Why?
| Occupations | 1 | 2019 | 26 | 0.060 |
Why?
| Fatal Outcome | 2 | 2014 | 299 | 0.060 |
Why?
| Critical Pathways | 1 | 2019 | 32 | 0.060 |
Why?
| Income | 1 | 2019 | 63 | 0.050 |
Why?
| Asymptomatic Diseases | 1 | 2019 | 35 | 0.050 |
Why?
| Clinical Competence | 1 | 2005 | 643 | 0.050 |
Why?
| Educational Status | 1 | 2019 | 165 | 0.050 |
Why?
| History, 21st Century | 1 | 2020 | 163 | 0.050 |
Why?
| Medical Order Entry Systems | 1 | 2018 | 25 | 0.050 |
Why?
| History, 20th Century | 1 | 2020 | 304 | 0.050 |
Why?
| Neurosurgical Procedures | 1 | 2020 | 149 | 0.050 |
Why?
| Developing Countries | 1 | 2018 | 66 | 0.050 |
Why?
| Osmolar Concentration | 1 | 2018 | 193 | 0.050 |
Why?
| Asia, Western | 1 | 2017 | 1 | 0.050 |
Why?
| Pulmonary Embolism | 1 | 2019 | 175 | 0.050 |
Why?
| Regional Blood Flow | 1 | 2017 | 196 | 0.050 |
Why?
| Emigrants and Immigrants | 1 | 2017 | 28 | 0.050 |
Why?
| Midwestern United States | 1 | 2017 | 71 | 0.050 |
Why?
| Emigration and Immigration | 1 | 2017 | 47 | 0.050 |
Why?
| Phenytoin | 1 | 2016 | 19 | 0.050 |
Why?
| Piracetam | 1 | 2016 | 11 | 0.050 |
Why?
| Single-Blind Method | 1 | 2017 | 144 | 0.050 |
Why?
| Up-Regulation | 1 | 2020 | 664 | 0.050 |
Why?
| Phantoms, Imaging | 1 | 2019 | 363 | 0.050 |
Why?
| Pandemics | 1 | 2020 | 315 | 0.040 |
Why?
| Leptospira | 1 | 2016 | 1 | 0.040 |
Why?
| Europe | 1 | 2017 | 284 | 0.040 |
Why?
| Mechanical Thrombolysis | 1 | 2016 | 12 | 0.040 |
Why?
| Craniotomy | 1 | 2016 | 84 | 0.040 |
Why?
| India | 1 | 2016 | 116 | 0.040 |
Why?
| Angiography, Digital Subtraction | 1 | 2016 | 76 | 0.040 |
Why?
| American Heart Association | 1 | 2015 | 66 | 0.040 |
Why?
| Molecular Diagnostic Techniques | 1 | 2016 | 73 | 0.040 |
Why?
| Personal Satisfaction | 1 | 2015 | 47 | 0.040 |
Why?
| von Willebrand Factor | 1 | 2014 | 35 | 0.040 |
Why?
| Brain Waves | 1 | 2014 | 29 | 0.040 |
Why?
| Trauma Severity Indices | 1 | 2013 | 29 | 0.040 |
Why?
| Consensus Development Conferences as Topic | 1 | 2013 | 27 | 0.040 |
Why?
| Polymerase Chain Reaction | 1 | 2016 | 987 | 0.030 |
Why?
| Evidence-Based Medicine | 1 | 2015 | 412 | 0.030 |
Why?
| Feasibility Studies | 1 | 2015 | 680 | 0.030 |
Why?
| Internet | 1 | 2015 | 293 | 0.030 |
Why?
| Societies, Medical | 1 | 2015 | 468 | 0.030 |
Why?
| Oxygen | 1 | 2017 | 655 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 2015 | 1583 | 0.030 |
Why?
| Electroencephalography | 1 | 2014 | 622 | 0.030 |
Why?
| Infant, Newborn | 1 | 2016 | 2244 | 0.030 |
Why?
| Heart Valve Prosthesis Implantation | 1 | 2011 | 126 | 0.030 |
Why?
| Infant | 1 | 2016 | 2926 | 0.030 |
Why?
| Cerebral Cortex | 1 | 2013 | 556 | 0.030 |
Why?
| Rats | 1 | 2016 | 4245 | 0.030 |
Why?
| Child, Preschool | 1 | 2016 | 3572 | 0.030 |
Why?
| Thrombocytopenia | 1 | 2009 | 149 | 0.030 |
Why?
| Smoking | 1 | 2012 | 543 | 0.020 |
Why?
| Glycine Agents | 1 | 2007 | 5 | 0.020 |
Why?
| Contrast Media | 1 | 2012 | 998 | 0.020 |
Why?
| Retroperitoneal Space | 1 | 2007 | 37 | 0.020 |
Why?
| Coma | 1 | 2007 | 36 | 0.020 |
Why?
| Child | 1 | 2016 | 6077 | 0.020 |
Why?
| Ischemic Preconditioning | 1 | 2005 | 37 | 0.020 |
Why?
| Indoles | 1 | 2007 | 301 | 0.020 |
Why?
|
|
Prabhakaran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|